Form 4 for SRTA Strata Critical Medical, Inc.
Accepted 2026-01-05 00:00:00 ET · period of report 2026-01-02 · accession 0001628280-26-000460 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | 2026-01-02 | SRTA | Tomkiel Melissa M. | GC, Co-CEO, Dir | M - OptEx | $0.18 | +277.0K | 1.64M | +20% | +$49.9K |
| D | 2026-01-05 | 2026-01-02 | SRTA | Tomkiel Melissa M. | GC, Co-CEO, Dir | M - OptEx | $0.00 | -277.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A common stock, $0.0001 par value per share | 2026-01-02 | M | A | 276,960 | $0.18 | 1,643,362 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2026-01-02 | M | D | 276,960 | $0.00 | 0 | D | $0.18 · 2021-05-07 to 2030-07-28 | 276,960 Class A common stock, $0.0001 par value per share |